Matthew Taylor
Stock Analyst at Jefferies
(4.41)
# 1,217
Out of 5,070 analysts
674
Total ratings
54.1%
Success rate
6.7%
Average return
Main Sectors:
Stocks Rated by Matthew Taylor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PODD Insulet | Reiterated: Buy | $400 → $190 | $142.64 | +33.20% | 31 | Oct 12, 2026 | |
| SYK Stryker | Reiterated: Buy | $455 → $405 | $304.40 | +33.05% | 36 | Sep 22, 2026 | |
| BSX Boston Scientific | Reiterated: Buy | $60 | $45.58 | +31.64% | 54 | Sep 11, 2026 | |
| EW Edwards Lifesciences | Reiterated: Buy | $102 → $105 | $88.29 | +18.93% | 69 | Sep 11, 2026 | |
| BDX Becton, Dickinson and Company | Reiterated: Buy | $210 | $193.80 | +8.36% | 31 | Sep 8, 2026 | |
| ESTA Establishment Labs Holdings | Reiterated: Buy | $63 → $105 | $60.99 | +72.16% | 11 | Sep 8, 2026 | |
| MDT Medtronic | Reiterated: Hold | $95 | $94.63 | +0.39% | 41 | Sep 2, 2026 | |
| ABT Abbott Laboratories | Reiterated: Buy | $135 | $102.45 | +31.77% | 44 | Aug 21, 2026 | |
| GEHC GE HealthCare Technologies | Reiterated: Buy | $90 → $92 | $70.23 | +31.00% | 13 | Jul 30, 2026 | |
| RMD ResMed | Reiterated: Hold | $245 → $225 | $245.50 | -8.35% | 16 | Jul 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $105 → $110 | $100.39 | +9.57% | 13 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $112 | $85.74 | +30.63% | 36 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $19 | $24.51 | -22.48% | 34 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $105 → $115 | $78.96 | +45.64% | 30 | Jan 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 | $16.52 | +190.56% | 11 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $15 → $12 | $18.40 | n/a | 3 | Oct 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $19 | $18.72 | n/a | 1 | Aug 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $79 → $80 | $79.72 | n/a | 13 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $130 → $110 | $96.00 | n/a | 28 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $20.54 | n/a | 1 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $0.475 | n/a | 4 | Jun 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $438.00 | n/a | 24 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $215 → $145 | $131.15 | n/a | 32 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33.00 → $34.50 | $14.52 | n/a | 2 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $16 → $15 | $14.14 | n/a | 23 | Apr 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $0.5 → $6 | $8.21 | n/a | 3 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 → $48 | $13.33 | n/a | 16 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $105 | $47.58 | n/a | 1 | Feb 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $14 | $5.82 | n/a | 1 | Jan 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | CHF 364.00 → CHF 255.00 | CHF 278.60 | n/a | 13 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $75 | $0.429 | n/a | 1 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $230 | $324.34 | n/a | 1 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7 → $5.5 | $7.31 | n/a | 2 | Mar 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $163.92 | n/a | 2 | Feb 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €49.00 | €23.12 | n/a | 21 | Jan 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $41.44 | n/a | 1 | Dec 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $1.5 → $1 | $5.61 | n/a | 9 | Mar 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $17 → $16 | $11.81 | n/a | 2 | Jul 19, 2017 |
Insulet
Oct 12, 2026
Reiterated: Buy
Price Target: $400 → $190
Current: $142.64
Upside: +33.20%
Stryker
Sep 22, 2026
Reiterated: Buy
Price Target: $455 → $405
Current: $304.40
Upside: +33.05%
Boston Scientific
Sep 11, 2026
Reiterated: Buy
Price Target: $60
Current: $45.58
Upside: +31.64%
Edwards Lifesciences
Sep 11, 2026
Reiterated: Buy
Price Target: $102 → $105
Current: $88.29
Upside: +18.93%
Becton, Dickinson and Company
Sep 8, 2026
Reiterated: Buy
Price Target: $210
Current: $193.80
Upside: +8.36%
Establishment Labs Holdings
Sep 8, 2026
Reiterated: Buy
Price Target: $63 → $105
Current: $60.99
Upside: +72.16%
Medtronic
Sep 2, 2026
Reiterated: Hold
Price Target: $95
Current: $94.63
Upside: +0.39%
Abbott Laboratories
Aug 21, 2026
Reiterated: Buy
Price Target: $135
Current: $102.45
Upside: +31.77%
GE HealthCare Technologies
Jul 30, 2026
Reiterated: Buy
Price Target: $90 → $92
Current: $70.23
Upside: +31.00%
ResMed
Jul 10, 2026
Reiterated: Hold
Price Target: $245 → $225
Current: $245.50
Upside: -8.35%
Mar 18, 2026
Reiterated: Buy
Price Target: $105 → $110
Current: $100.39
Upside: +9.57%
Feb 13, 2026
Reiterated: Buy
Price Target: $112
Current: $85.74
Upside: +30.63%
Feb 12, 2026
Reiterated: Hold
Price Target: $19
Current: $24.51
Upside: -22.48%
Jan 8, 2026
Reiterated: Buy
Price Target: $105 → $115
Current: $78.96
Upside: +45.64%
Nov 7, 2025
Reiterated: Buy
Price Target: $48
Current: $16.52
Upside: +190.56%
Oct 3, 2025
Reiterated: Hold
Price Target: $15 → $12
Current: $18.40
Upside: n/a
Aug 25, 2025
Initiated Coverage: Buy
Price Target: $19
Current: $18.72
Upside: n/a
Aug 7, 2025
Reiterated: Buy
Price Target: $79 → $80
Current: $79.72
Upside: n/a
Aug 7, 2025
Reiterated: Hold
Price Target: $130 → $110
Current: $96.00
Upside: n/a
Aug 5, 2025
Reiterated: Buy
Price Target: $28
Current: $20.54
Upside: n/a
Jun 4, 2025
Reiterated: Buy
Price Target: $18
Current: $0.475
Upside: n/a
May 2, 2025
Reiterated: Hold
Price Target: n/a
Current: $438.00
Upside: n/a
May 1, 2025
Reiterated: Hold
Price Target: $215 → $145
Current: $131.15
Upside: n/a
Apr 28, 2025
Reiterated: Buy
Price Target: $33.00 → $34.50
Current: $14.52
Upside: n/a
Apr 14, 2025
Upgraded: Buy
Price Target: $16 → $15
Current: $14.14
Upside: n/a
Mar 4, 2025
Reiterated: Sell
Price Target: $0.5 → $6
Current: $8.21
Upside: n/a
Jul 16, 2024
Reiterated: Buy
Price Target: $50 → $48
Current: $13.33
Upside: n/a
Feb 1, 2024
Reiterated: Hold
Price Target: $105
Current: $47.58
Upside: n/a
Jan 19, 2024
Initiated Coverage: Buy
Price Target: $14
Current: $5.82
Upside: n/a
Oct 28, 2022
Reiterated: Hold
Price Target: CHF 364.00 → CHF 255.00
Current: CHF 278.60
Upside: n/a
Oct 12, 2022
Initiated Coverage: Hold
Price Target: $75
Current: $0.429
Upside: n/a
Oct 12, 2022
Initiated Coverage: Buy
Price Target: $230
Current: $324.34
Upside: n/a
Mar 1, 2022
Reiterated: Hold
Price Target: $7 → $5.5
Current: $7.31
Upside: n/a
Feb 7, 2022
Upgraded: Buy
Price Target: n/a
Current: $163.92
Upside: n/a
Jan 25, 2022
Reiterated: Buy
Price Target: €49.00
Current: €23.12
Upside: n/a
Dec 6, 2019
Reiterated: Hold
Price Target: n/a
Current: $41.44
Upside: n/a
Mar 8, 2018
Reiterated: Sell
Price Target: $1.5 → $1
Current: $5.61
Upside: n/a
Jul 19, 2017
Reiterated: Hold
Price Target: $17 → $16
Current: $11.81
Upside: n/a